Investigations
Investigations
Harvard Psychiatrists Primed For a Fall
The New York Times reports that Federal prosecutors have issued a subpoena seeking information and all documents including transcripts of their testimony produced in litigation relating to three prominent Harvard researchers…
Read MoreGrassley to Harvard & Mass General: Biederman Protocol Breach
The most shocking disclosure: a Biederman study testing the use of powerful antipsychotics in PRESCHOOL CHILDREN "was beset by breaches of research protocol."
Read MoreBiederman J & J Risperdal Documents
An early e-mail (dated 1999) states: "Dr. Biederman is not someone to jerk around. He is a very proud national figure in child psych and has a very short fuse."
Read MorePharma Giants Under Investigation by UK Serious Fraud Office
The Guardian reports that the Serious Fraud Office has launched an investigation into allegations that a number of major UK-based firms paid bribes to Saddam Hussein's regime in Iraq.
Read MoreProminent USC Geneticist Sentenced to 14 Years for Molesting Girl_AP
In sentencing William French Anderson, the judge said: "Because of intellectual arrogance, he persisted and he got away with as much as he could."
Read MoreCong. Hearings Loom: Pfizer, Halliburton
“No general counsel or CEO wants to have to explain to his board why the company's name is appearing on the front page of a news article in a scandal…"
Read MoreOHRP Letter to ARDSNetwork re: Investigation of Acute Respiratory DistressSyndrome
OHRP Investigation of experimental treatment for Acute Respiratory Distress Syndrome. ARDSNet studies: ARMA, FACCT, and ALVEOLI Table of Contents to Fax from OHRP page 1 Oct. 7, 2002 OHRP letter to: Ronald S. Newvbower, Ph.D(Mass. General Hospital), Lee E. Limbird, Ph.D. (Vanderbilt University), and Robert Kay, MD) (Cleveland Clinic Foundation) page 2 “OHRP continues to…
Read MoreJapan Links 81 Deaths to new Lung Cancer Drug
Japan Links 81 Deaths to new Lung Cancer Drug Thu, 5 Dec 2002 Now a days, the fate of a drug depends not so much on its efficacy and safety, but rather on the financial needs of the manufacturer and the company’s ability to round up an “independent” panel of experts to give the drug…
Read MoreFDA Is Flexing Less Muscle where Safety is the Issue – Wash Post
FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004 The Washington Post examines FDA’s record of surveillance and the evidence is clear: since 1992 when Congress required drug companies to pay users fees to the FDA, the agency’s focus changed from safety concerns to business concerns. Curt…
Read MoreNIH Under Fire: Longtime Favorite of Congress – Wash Post / WSJ
NIH Under Fire: Longtime Favorite of Congress – Wash Post / WSJ Sun, 27 Jun 2004 Under fire from Congress with evidence of NIH staff engaging in secret outside contracts and consultancies, NIH Director, Dr. Elias Zerhouni, turned a corner. He acknowledged the problem at a hearing (June 22) of the House oversight subcommittee of…
Read MoreFour Top Doctors Arrested for illegal medical experiments_Israel
According to a investigative report issued by the Israeli Health Ministry, the doctors "conducted illegal and unethical testing on thousands of elderly patients for years.
Read MorePsychiatrist criminally indicted: Promoting off-label use of drug for depression!
The New York Times reports that a Maryland psychiatrist, Dr. Peter Gleason, was handcuffed and arrested in March and charged with criminal promotion of a drug "for purposes other than those approved by the federal government."
Read More